Currently being used at Scripps...identifies genetic determinants of cardiovascular disease and can produce up to 225 million genotypes per day with one scanner...BD
Illumina, Inc. (NASDAQ:ILMN) launched the iScan System, a next-generation scanner that provides researchers conducting genotyping and gene expression studies with significantly greater throughput, enhanced automation, and improved ease of use. When used with the recently launched Infinium® High-Density (HD) Human1M-Duo and
Human610-Quad Genotyping BeadChips, and Illumina's laboratory information management systems and automation options, the iScan System can complete genotyping studies up to six times faster than studies run on Illumina's BeadStation.
Illumina's versatile VeraCode technology is the ideal molecular diagnostics tool as it analyzes both DNA and RNA at high throughput with the ability to target single to several hundred analytes in a single sample.
0 comments :
Post a Comment